Sullivan named President of Avion Pharmaceuticals

Avion Pharmaceuticals, a specialty pharmaceutical company formed to develop and market a portfolio of products in the women's heath and dermatology therapeutic area, has announced the promotion of Mike Sullivan to the position of President.

Sullivan joined Avion Pharmaceuticals in 2011 as vice president of sales and marketing. Tapped for his expertise in building corporate start-up pharmaceutical organizations, he has been instrumental in the commercial development, infrastructure and successful launch of Avion over the past three years. Sullivan's career history has included senior management positions with UCB Pharma, Novartis, Sanofi and Ther-Rx Pharmaceuticals.

"I am pleased to announce Mike's promotion and applaud his inexhaustible dedication to drive continuous success for Avion Pharmaceuticals. Mike exhibits endless passion in realizing our strategic mission to be the leading pharmaceutical company in the U.S. devoted to women's healthcare. With Mike's leadership, Avion is positioned to continue our growth through innovation by providing women and babies with products and support needed to live healthy and rewarding lives," said Mark Pugh, CEO of Avion.